º£½ÇÊÓƵ

Load mobile navigation

Pharmaceuticals

FTSE 100 climbs sharply as US-focused º£½ÇÊÓƵ firms benefit from Trump's presidency
By City AM
The FTSE 100 surged at the open today, and sterling crashed as traders digested how Donald Trump's presidency will impact the global economy and the º£½ÇÊÓƵ
Bookmark
Newcastle health firm to create skilled jobs with £50m Government-backed investment
Economy
A new state-of-the-art manufacturing facility will be built in Newcastle to supply life saving medicines to the NHS and European health systems
Bookmark
Budget 2024: North East business leaders react to first Labour fiscal statement in 14 years
The Budget
Business leaders from across the region have delivered their verdict on Rachel Reeves' first budget
Bookmark
GSK maintains 2024 financial outlook despite profit plunge from Zantac lawsuit settlements
By City AM
The pharmaceutical giant reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and said its core outlook remained unchanged.
Bookmark
York's Aptamer Group hails commercial traction after narrowing losses in challenging conditions
Company Results
'We have underscored the growing demand for Optimer technology' says CEO Arron Tolley
Bookmark
SkinBioTherepeutics completes second acquisition with deal for Yorkshire firm BTS
Deals
The Newcastle life sciences firm said the acquisition showed how it was transforming its business
Bookmark
GSK resolves Zantac cancer claims with a £1.7 billion settlement, boosting shares
By City AM
The pharmaceutical giant has agreed to a $2.2bn (£1.68bn) settlement to resolve lawsuits in the US alleging that the company's Zantac heartburn drug had caused cancer
Bookmark
The Geordie businessman who has returned to inspire the region's young people into entrepreneurship
People
Tom Keighley speaks to Rob Wood about the Enterprising Futures Academy he has set up in the city
Bookmark
AstraZeneca invests in future of heart health with $2bn licensing agreement for dyslipidemia drug
By City AM
The Anglo-Swedish pharmaceutical giant will make an upfront payment of $100m to licence a preclinical small molecule aimed at treating dyslipidemia, an imbalanced, abnormal level of lipids in the bloodstream
Bookmark
Abingdon Health narrows losses as revenues rise more than 50%
Technology
The York-based firm has made two acquisitions this year and completed a £5.6m fundraise
Bookmark
50-year-old transport firm John K Philips Group moves to carbon-neutral Warrington headquarters
BT
Business founded in 1974 after John Philips bought a truck to deliver paint
Bookmark
Life sciences firm Gentronix set for ‘fantastic next step’ after it is acquired by Danish group Scantox
Tech
Gentronix 'well recognised for its high-quality genetic toxicology services'
Bookmark
AstraZeneca: Treasury says ‘positive discussions’ ongoing over future of £450m vaccine plant
Pharmaceuticals
Company and Government repeat upbeat messages despite reports state funding could be cut
Bookmark
Fusion Antibodies reports challenging year with revenue drop but sees growth in sales pipeline
By City AM
Shares in the AIM-listed firm sprung up 7.5 per cent when the market opened on Thursday
Bookmark
Shield Therapeutics builds revenues as US prescriptions grow
Company Results
Interim chief executive Anders Lundstrom said the loss making firm had its 'cash burn' under control as it targets the stateside iron deficiency market
Bookmark
GSK and Pfizer challenge expert testimony in Zantac cancer case at Delaware Supreme Court
By City AM
Delaware's top court is set to hear an appeal from GSK and other pharmaceutical giants to throw out over 70,000 lawsuits alleging that the now-discontinued heartburn drug Zantac caused cancer
Bookmark
Shield Therapeutics to enter Canadian market following approval of iron deficiency drug
Pharmaceuticals
Shares rose on the news that Health Canada had approved the firm's Accrufer tablets
Bookmark
Teesside pharma firm Fujifilm Diosynth Biotechnologies opens new £100m facility in Billingham
Pharmaceuticals
Business leaders and Government officials have attended a grand opening ceremony
Bookmark
AstraZeneca's Imfinzi gains US approval, boosting treatment options for early-stage lung cancer
By City AM
Imfinzi, which is used alongside chemotherapy to treat early-stage non-small cell lung cancer, is given before and after surgery and is the first immunotherapy approved for this indication
Bookmark
Newcastle biotech business Kerato strikes partnership with Canadian university
Deals
The two organisations will work together towards commercialising lab-grown corneas
Bookmark
Northumberland's Piramal Healthcare sees revenues rise as order pipeline grows
Pharmaceuticals
The Morpeth business, which also has a Grangemouth site, also narrowed its losses
Bookmark
GSK secures victory in latest Zantac trial: Jury dismisses claims linking drug to cancer
By City AM
The London-listed pharmaceutical giant has faced a barrage of lawsuits over whether or not Zantac - once the best selling drug in the world - was carcinogenic.
Bookmark
Newcastle skincare innovator SkinBioTherapeutics lands £1.56m investment to support growth
Pharmaceuticals
CEO Stuart Ashman said it was rare for small cap companies such as his to be approached by larger investors
Bookmark
GSK raises guidance after strong second quarter boosted by cancer and HIV portfolio
By City AM
Total sales in the second quarter of 2024 reached £7.9bn, an increase of 13 per cent year on year while core operating profit at the pharma company rose by 18 per cent
Bookmark
Story Saved
You can find this story in  My Bookmarks.Or by navigating to the user icon in the top right.